利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

130 条记录 (耗时 0.026 秒)

    Thymidine derivatives and therapeutic method of use
    1.
    发明授权
    Thymidine derivatives and therapeutic method of use 失效
    胸苷衍生物及其治疗方法

    公开(公告)号：US5306722A

    公开(公告)日：1994-04-26

    申请号：US939232

    申请日：1992-09-02

    申请人： Choung U. Kim ,  Bing Y. Luh ,  Peter F. Misco

    发明人： Choung U. Kim ,  Bing Y. Luh ,  Peter F. Misco

    IPC分类号： A61K31/505 ,  A61P31/12 ,  C07D405/04 ,  C07H19/06 ,  C07D403/04

    CPC分类号： C07H19/06

    摘要： Thymidine kinase inhibitor of formula I ##STR1## in which R is C.sub.1-6 alkyl or AR(CH.sub.2).sub.n --, wherein Ar represents phenyl optionally substituted with one to five same or different halogen, C.sub.1-6 alkyl or C.sub.1-6 alkyloxy; and n equals one to six.A further aspect of the present invention provides a method of inhibiting viral thymidine kinase. Yet another aspect of the invention relates to treating herpes simplex viral infections in mammals. Yet another aspect of the invention provides a pharmaceutical formulation.

    摘要翻译： 式I的胸苷激酶抑制剂（*化学结构*）I其中R是C 1-6烷基或AR（CH 2）n - ，其中Ar表示任选被1至5个相同或不同的卤素，C 1-6烷基或C 1 -C 6烷基取代的苯基， 6烷氧基; n等于1到6。 本发明的另一方面提供了抑制病毒胸苷激酶的方法。 本发明的另一方面涉及治疗哺乳动物中的单纯疱疹病毒感染。 本发明的另一方面提供一种药物制剂。

    Carbapenem antibiotics
    5.
    发明授权
    Carbapenem antibiotics 失效

    公开(公告)号：US4665170A

    公开(公告)日：1987-05-12

    申请号：US822576

    申请日：1986-01-27

    申请人： Choung U. Kim ,  Peter F. Misco, Jr.

    发明人： Choung U. Kim ,  Peter F. Misco, Jr.

    IPC分类号： C07D295/088 ,  C07D477/20 ,  C07D487/04 ,  A61K31/40

    CPC分类号： C07D295/088 ,  C07D477/20

    摘要： Disclosed are novel carbapenem derivatives characterized by a 2-substituent of the formula ##STR1## in which A represents cyclopentylene, cyclohexylene or C.sub.2 -C.sub.6 alkylene optionally substituted by one or more C.sub.1 -C.sub.4 alkyl groups; R.sup.5 represents either (a) an optionally substituted aliphatic, cycloaliphatic, cycloaliphatic-aliphatic, aryl, araliphatic, heteroaryl, heteroaraliphatic, heterocyclyl or heterocyclyl-aliphatic radical or (b) a divalent phenylene or C.sub.1 -C.sub.4 alkylene group joined to the ##STR2## ring so as to form a bridged polycyclic group; and ##STR3## represents a quaternized nitrogen-containing non-aromatic heterocycle. Such derivatives are useful as potent antibacterial agents.

    Carbapenem antibiotics
    6.
    发明授权
    Carbapenem antibiotics 失效
    卡巴布本抗生素

    公开(公告)号：US4640799A

    公开(公告)日：1987-02-03

    申请号：US762735

    申请日：1985-08-05

    申请人： Choung U. Kim ,  Peter F. Misco, Jr.

    发明人： Choung U. Kim ,  Peter F. Misco, Jr.

    IPC分类号： C07D295/088 ,  C07D477/20 ,  C07D487/04 ,  A61K31/40

    CPC分类号： C07D295/088 ,  C07D477/20

    摘要： Disclosed are novel carbapenem derivatives characterized by a 2-substituent of the formula ##STR1## in which A represents cyclopentylene, cyclohexylene or C.sub.2 -C.sub.6 alkylene optionally substituted by one or more C.sub.1 -C.sub.4 alkyl groups; R.sup.5 represents either (a) an optionally substituted aliphatic, cycloaliphatic, cycloaliphatic-aliphatic, aryl, araliphatic, heteroaryl, heteroaraliphatic, heterocyclyl or heterocyclyl-aliphatic radical or (b) a divalent phenylene or C.sub.1 -C.sub.4 alkylene group joined to the ##STR2## ring so as to form a bridged polycyclic group; and ##STR3## represents a quaternized nitrogen-containing non-aromatic heterocycle. Such derivatives are useful as potent antibacterial agents.

    摘要翻译： 公开了新的碳青霉烯衍生物，其特征在于具有式“IMAGE”的2-取代基，其中A表示任选被一个或多个C 1 -C 4烷基取代的亚环戊基，亚环己基或C 2 -C 6亚烷基; R 5表示（a）任选取代的脂族，脂环族，脂环族 - 脂族，芳基，芳脂族，杂芳基，杂脂肪族基，杂环基或杂环基 - 脂族基团或（b）二价亚苯基或C1-C4亚烷基， 环以形成桥连多环基团; 并且表示季铵化的含氮非芳族杂环。 这些衍生物可用作有效的抗菌剂。

    Cephalosporin derivatives
    8.
    发明授权
    Cephalosporin derivatives 失效
    头孢菌素衍生物

    公开(公告)号：US5734047A

    公开(公告)日：1998-03-31

    申请号：US761738

    申请日：1996-12-05

    申请人： Choung U. Kim ,  Muzammil M. Mansuri ,  Peter F. Misco ,  John A. Wichtowski

    发明人： Choung U. Kim ,  Muzammil M. Mansuri ,  Peter F. Misco ,  John A. Wichtowski

    IPC分类号： C07D501/00 ,  C07D501/36 ,  A61K31/545

    CPC分类号： C07D501/00

    摘要： Novel cephem derivatives represented by the general formula ##STR1## wherein Ar is an optionally substituted lipophilic phenyl, naphthyl, benzthiazolyl or pyridyl group; R.sup.1 represents a group of the formula ##STR2## in which R.sup.8 and R.sup.9 are each independently hydrogen, C.sub.1 -C.sub.6 alkyl or (C.sub.1 -C.sub.6)alkoxycarbonyl, said C.sub.1 -C.sub.6 alkyl group being optionally substituted by 1-5 hydroxy or C.sub.1 -C.sub.6 alkoxy groups; m is either 0 or 1; A is a C.sub.2 -C.sub.10 alkyl group optionally substituted by 1-5 hydroxy groups; and R.sup.2 and R.sup.3 are each independently hydrogen or C.sub.1 -C.sub.6 alkyl. The derivatives are gram-positive antibacterial agents especially useful in the treatment of diseases caused by methicillin-resistant Staphylococcus aureus.

    摘要翻译： 由通式 + TR 表示的新型头孢烯衍生物，其中Ar是任选取代的亲脂性苯基，萘基，苯并噻唑基或吡啶基; R 1表示式（VIII）的基团，其中R 8和R 9各自独立地为氢，C 1 -C 6烷基或（C 1 -C 6）烷氧基羰基，所述C 1 -C 6烷基任选被1-5个羟基或C 1 -C 6 烷氧基 m为0或1; A是任选被1-5个羟基取代的C 2 -C 10烷基; 且R 2和R 3各自独立地为氢或C 1 -C 6烷基。 衍生物是革兰氏阳性抗菌剂，特别适用于治疗耐甲氧西林金黄色葡萄球菌引起的疾病。